Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin

Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.

Authors

Hongde Hu¹, Fenglian Ma², Xin Wei¹, Yuan Fang¹

Affiliations

¹ Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, PR China.
² The Postgraduation Training Department of West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu 610041, PR China.

No abstract available

Publication types

Case Reports

MeSH terms

Adult
COVID-19 / complications*
COVID-19 / epidemiology
COVID-19 / virology
Drug Therapy, Combination
Glucocorticoids / therapeutic use*
Humans
Immunoglobulins / therapeutic use*
Male
Myocarditis / drug therapy*
Myocarditis / etiology
Myocarditis / virology
Pandemics
SARS-CoV-2*

Substances

Glucocorticoids
Immunoglobulins